Publikationen von Anke Bentmann

Klemis, V.; Ghura, H.; Federico, G.; Wuerfel, C.; Bentmann, A.; Gretz, N.; Miyazaki, T.; Groene, H.-J.; Nakchband, I. A.: Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney International 91 (6), S. 1374 - 1385 (2017)

Bentmann, A.; Kawelke, N.; Moss, D.; Zentgraf, H.; Bala, Y.; Berger, I.; Gasser, J. A.; Nakchbandi, I. A.: Circulating Fibronectin Affects Bone Matrix, Whereas Osteoblast Fibronectin Modulates Osteoblast Function. Journal of Bone and Mineral Research 25 (4), S. 706 - 715 (2010)

Bentmann, A.; Kawelke, N.; Moss, D.; Nakchbandi, I.: Circulating Fibronectin Affects Bone Matrix. Journal of Bone and Mineral Research 23 (Suppl. Suppl. S), S. S163 - S163 (2008)

Kawelke, N.; Bentmann, A.; Hackl, N.; Hager, H. D.; Feick, P.; Geursen, A.; Singer, M. V.; Nakchbandi, I. A.: Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. Journal of Bone and Mineral Research 23 (8), S. 1278 - 1286 (2008)

Bentmann, A.; Kawelke, N.; Gasser, J.; Nakchbandi, I. A.: Circulating plasma fibronectin is needed for a normal bone density. Calcified Tissue International 82 (Suppl. Suppl. 1), S. S97 - S97 (2008)

Bentmann, A.; Kawelke, N.; Moss, D.; Nakchbandi, I. A.: Osteoblast fibronectin affects their behavior in vivo. Calcified Tissue International 82 (Suppl. Suppl. 1), S. S97 - S97 (2008)

Kawelke, N.; Bentmann, A.; Hackl, N.; Nakchbandi, I. A.: Bone loss in patients with primary biliary cirrhosis is caused by a fibronectin isoform. Calcified Tissue International 82 (Suppl. Suppl. 1), S. S106 - S106 (2008)